Therapy Areas: Oncology
Marengo Therapeutics names new chief financial officer
17 June 2022 -

Marengo Therapeutics Inc, a US-based company pioneering novel therapeutics that directly target the V beta chain of the T cell receptor (TCR) to activate the right T cell subsets to fight cancer, announced on Wednesday the appointment of Svetlana Makhni as its new chief financial officer.

Makhni has more than 15 years of experience in finance, business development and operations. She has previously served as chief financial officer at Escient Pharmaceuticals, chief financial officer and head of Operations at Bierman ABA, and spent nearly a decade in healthcare investment banking at several top financial institutions including BMO Capital Markets, Goldman Sachs, Westbrook Partners and the Blackstone Group.

Makhni holds a BS in Finance and Accounting from The Wharton School and an MBA from Harvard Business School.